Injection site reactions: Redness, swelling, or irritation at injection sites
Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, [PMID: 28210905] Laboratory literature summary: Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, L-NAME and L-arginine worsen
Importantly, BPC-157 is currently classified as a research peptide
Synergistic Angiogenesis and Microvascularization: Investigating how BPC-157s nitric oxide pathways pair with TB-500s endothelial cell migration to promote rapid blood vessel growth to poorly vascularized tissues
By supporting both energy production and neural connectivity, this approach represents a broader and more integrated direction in brain optimization
GLOW Peptide Storage & Handling Storage Reference (All Three Compounds) State Lyophilized (Powder Form) BPC-157 -4 F (-20 C) long-term TB-500 -4 F (-20 C) long-term GHK-Cu -4 F (-20 C) long-term State Reconstituted (Liquid Form) BPC-157 35.6-46.4 F (2-8 C), up to 30 days TB-500 35.6-46.4 F (2-8 C), 1-2 weeks GHK-Cu 35.6-46.4 F (2-8 C), up to 30 days State Appearance BPC-157 Clear TB-500 Clear GHK-Cu May be light blue/green State Freeze reconstituted BPC-157 Aliquots possible TB-500 Do not freeze GHK-Cu Do not freeze TB-500 has the shortest reconstituted-stability window